LifeStance Health Group, Inc. (LFST) Tops Q3 EPS by 5c, raises guidance

LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q3 EPS of ($0.02), $0.05 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $312.7 million versus the consensus estimate of $302.25 million.

GUIDANCE:

LifeStance Health Group, Inc. sees FY2024 revenue of $1.228-1.248 billion, versus the consensus of $1.225 billion.

For earnings history and earnings-related data on LifeStance Health Group, Inc. (LFST) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lockheed Martin wins $2.8B in Defense contracts for F-35, helicopters
• Circle board member resigns after nearly 13 years of service